GSK is boosting its RNA ambitions, announcing Thursday it has acquired a small, privately held San Diego startup called Elsie Biotechnologies that the British drugmaker …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.